Treatment of refractory adult-onset pityriasis rubra pilaris with TNF-alpha antagonists: A case series

Journal of the European Academy of Dermatology and Venereology

Volumn 24, Issue 8, 2010, Pages 881-884

  Garcovich, S ^a   Di Giampetruzzi, A R ^b   Antonelli, G ^b   Garcovich, A ^a   Didona, B ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

etanercept; infliximab; pityriasis rubra pilaris; recurrence

Indexed keywords

ADALIMUMAB; CYCLOSPORIN A; ETANERCEPT; ETRETIN; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; PSORALEN; RETINOID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BODY SURFACE; CASE STUDY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; KERATODERMA; LONG TERM CARE; LOW DRUG DOSE; MALE; MONOTHERAPY; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; SKIN DEFECT; SYSTEMIC THERAPY; TREATMENT DURATION;

ACITRETIN; ADULT; ANTIBODIES, MONOCLONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; PITYRIASIS RUBRA PILARIS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954398515     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03511.x     Document Type: Article

References (15)

1. Griffiths WA. Pityriasis rubra pilaris: the problem of its classification. J Am Acad Dermatol 1992 26 : 140 142.
2. Akhyani M, Ghodsi ZS, Toosi S, Dabbaghian H. Erythroderma: a clinical study of 97 cases. BMC Dermatol 2005 5 : 5.
3. Artik S, Kuhn A, Neumann NJ, Ruzicka T, Megahed M. Pityriasis rubra pilaris. Hautarzt 2004 55 : 980 983.
4. Finzi AF, Altomare G, Bergamaschini L, Tucci A. Pityriasis rubra pilaris and retinol-binding protein. Br J Dermatol 1981 104 : 253 256. (Pubitemid 11060736)
5. Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol 1999 38 : 1 11.
6. Shahidullah H, Aldridge RD. Changing forms of juvenile pityriasis rubra pilaris - a case report. Clin Exp Dermatol 1994 19 : 254 256.
7. Abbott RA, Griffiths WA. Pityriasis rubra pilaris type 1 spontaneously resolving after 20 years. Clin Exp Dermatol 2009 34 : 378 379.
8. Ruiz-Genao DP, Lopez-Estebaranz JL, Naz-Villalba E. Pityriasis rubra pilaris successfully treated with infliximab. Acta Derm Venereol 2007 87 : 552 553.
9. Seckin D, Tula E, Ergun T. Successful use of etanercept in type I pityriasis rubra pilaris. Br J Dermatol 2007 158 : 642 644.
10. Walling HW, Swick BL. Pityriasis rubra pilaris responding rapidly to adalimumab. Arch Dermatol 2009 145 : 99 101.
11. Müller H, Gattringer C, Zelger B, Höpfl R, Eisendle K. Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008 59 : 65 70.
12. Ruzzetti M, Saraceno R, Carboni I, Papoutsaki M, Chimenti S. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. J Eur Acad Dermatol Venereol 2008 22 : 117 118.
13. Davis KF, Wu JJ, Murase JE, Rosenberg FR, Sorenson EP, Meshkinpour A. Clinical improvement of pityriasis rubra pilaris with combination etanercept and acitretin therapy. Arch Dermatol 2007 143 : 1597 1599.
14. Lu R, George SJ, Hsu S Pityriasis rubra pilaris: failure of combination treatment with acitretin and infliximab. Dermatol Online J 2006 12 : 18.
15. Betlloch I, Ramón R, Silvestre JF, Carnero L, Albares MP, Bañuls J. Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease? Pediatr Dermatol 2001 18 : 411 414.